Translating report proportions to incidence proportions
Putting an end to our search for the elusive underreporting factor
It is my intention to demonstrate how proportional reporting differences in post-approval pharmacovigilance databases like VAERS can be leveraged to establish the side effect profile of a drug.
Today I want to compare several types of adverse events’ incidence proportions found in literature with the report proportions in the VAERS database that i…
Keep reading with a 7-day free trial
Subscribe to Vigilance per VAERS to keep reading this post and get 7 days of free access to the full post archives.